Tag: Diabetes: Type II
AHA: Low-Dose Aspirin Use Linked to Lower ASCVD Outcomes in Type 2 Diabetes
Any aspirin use linked to lower hazards of MI, ischemic stroke, with greater benefit in high-frequency use group
AHA: Optimal Heart Health Linked to Reduced MCI Risk in Type 2 Diabetes
Lower risk for MCI and dementia also seen with moderate, high cardiovascular health in those with high polygenic risk score
Type 2 Diabetes in Young Children Tied to Social, Environmental Factors
Childhood diabetes prevention programs should address broader issues of food access and quality, authors say
CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With...
20 percent greater mortality benefit seen in obstructive sleep apnea population
New Diagnosis Code Added for Patients With Type 2 Diabetes in Remission
New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least three months
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic,...
Even higher use seen in patients without type 2 diabetes
Continuous Glucose Monitors Not Accurate in People Without Diabetes
Authors say in those without diabetes, continuous glucose monitors are not a substitute for HbA1c
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
Findings seen for both medication and surgical procedures in people with obesity and type 2 diabetes
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Diabetes Tied to Doubled Risk for Sepsis
Smoking, high blood sugar, and other chronic conditions heighten risk












